Advertisement

Manipulation of T-Cell Populations to Abrogate Allograft Rejection

  • Charles B. Carpenter

Abstract

Selective intervention in the afferent or efferent arcs of the immune response in vivo has become a possibility because specific subsets of interacting cells can be identified by monoclonal antibodies directed to surface molecules that relate to specific functions. A subset of cells thus identified can be targeted for destruction, either by opsonization and/or complement-mediated lysis, or by internalization of toxins that have been conjugated to the antibody molecules. Other possibilities relate to the inhibition by specific monoclonal antibodies of cell surface receptors or interaction sites without actually destroying the cell, or to the neutralization of secreted molecules [e.g., interleukin 2 (IL-2) or interferon gamma (IFN-γ)].

Keywords

Allograft Rejection Renal Allograft Rejection Episode Mixed Lymphocyte Reaction Acute Rejection Episode 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carpenter, C. B., 1981, The cellular basis of allograft rejection, Immunol. Today 2:50.CrossRefGoogle Scholar
  2. 2.
    Strom, T. B., Tilney, N. L., Paradysz, J. M., Bancewicz, J., and Carpenter, C. B., 1977, Cellular components of allograft rejection: Identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts, J. Immunol. 118:2020.PubMedGoogle Scholar
  3. 3.
    Williams, G. M., Hume, D. M., Hudson, R. P., Morris, P. J., Kano, K., and Milgrom, F., 1968, “Hyperacute” renal homograft rejection in man, N. EngJ. J. Med. 279:611.CrossRefGoogle Scholar
  4. 4.
    Busch, G. J., Reynolds, E. S., Galvanek, E. C., Braun, W. E., and Dammin, G. J., 1971, Human renal allografts: The role of vascular injury in early graft failure, Medicine 50:29.PubMedCrossRefGoogle Scholar
  5. 5.
    Porter, K. A., The effects of antibodies on human renal allografts, 1976, Transplant. Proc. 8:189.PubMedGoogle Scholar
  6. 6.
    Porter, K. A., Joseph, N. H., Rendall, J. M., Stolinski, C., Hoehn, R. J., and Calne, R. Y., 1964, The role of lymphocytes in the rejection of canine renal homotransplants, Lab. Invest. 13:1080.PubMedGoogle Scholar
  7. 7.
    Tilney, N. L., Strom, T. B., MacPherson, S. G., and Carpenter, C. B., 1976, Studies on infiltrating host cells harvested from acutely rejecting rat cardiac allografts, Surgery 79:209.PubMedGoogle Scholar
  8. 8.
    Busch, G. J., Schamberg, J. F., Moretz, R. C., Strom, T. B., Tilney, N. L., and Carpenter, C. B., 1976, T and B cell patterns in irreversibly rejected human renal allografts: Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrate, Lab. Invest 35:272.PubMedGoogle Scholar
  9. 9.
    Berke, G., and Amos, D. B., 1973, Mechanism of lymphocyte-mediated cytolysis; The LMC cycle and its role in transplantation immunity, Transplant. Rev. 17:71.PubMedGoogle Scholar
  10. 10.
    Tilney, N. L., and Ford, W. L., 1974, The migration of rat lymphoid cells into skin grafts, Transplantation, 17:12.PubMedCrossRefGoogle Scholar
  11. 11.
    Bhan, A. K., Reinisch, C. L., Levey, R. H., McCluskey, R. T., and Schlossman, S. E., 1975, T-cell migration into allografts, J. Exp. Med. 141:1210.PubMedCrossRefGoogle Scholar
  12. 12.
    Balch, C. M., Wilson, C. B., Lee, S., and Feldman, J. D., 1973, Thymus-dependent lymphocytes in tissue sections of rejecting rat renal allografts, J. Exp. Med. 138:1584.PubMedCrossRefGoogle Scholar
  13. 13.
    Cerottini, J. C., and Brunner, K. T., 1974, Cell-mediated cytotoxicity, allograft rejection, and tumor immunity, Adv. Immunol. 18:67.PubMedCrossRefGoogle Scholar
  14. 14.
    Strom, R. B., Tilney, T. B., Carpenter, C. B., and Busch, G. J., 1975, Identity and cytotoxic capacity of cells infiltrating renal allografts, N. Engl. J. Med. 292:1257.PubMedCrossRefGoogle Scholar
  15. 15.
    Tilney, N. L., Strom, T. B., MacPherson, S. G., and Carpenter, C. B., 1975, Surface properties and functional characteristics of infiltrating cells harvested from acutely rejecting cardiac allografts in inbred rats, Transplantation 20:323.PubMedCrossRefGoogle Scholar
  16. 16.
    Roberts, P. J., and Hayry, P., 1976, Sponge matrix allografts. A model for analysis of killer cells infiltrating mouse allografts, Transplantation 21:437.PubMedCrossRefGoogle Scholar
  17. 17.
    Hancock, W. W., 1984, Analysis of intragraft effector mechanisms associated with human renal allograft rejection: Immunohistological studies with monoclonal antibodies, Immunol. Rev. 77:61.PubMedCrossRefGoogle Scholar
  18. 18.
    Pober, J. S., Gimbrone, M. A., Jr., Cotran, R. S., Reiss, C. S., Burakoff, S. J., Fiers, W., and Ault, K. A., 1983, La expression by vascular endothelium is inducible by activated T cells and by human γ-interferon, J. Exp. Med. 157:1339.CrossRefGoogle Scholar
  19. 19.
    Loveland, B. E., and McKenzie, I. F. C., 1982, Which T cells cause graft rejection? Transplantation 33:217.PubMedGoogle Scholar
  20. 20.
    Dallman, M. J., and Mason, D. W., 1982, Role of thymus derived and thymus-independent cells in murine skin allograft rejection, Transplantation 33:221.PubMedCrossRefGoogle Scholar
  21. 21.
    Busch, G. J., Schamberg, J. F., Moretz, R. C., Strom, T. B., Tilney, N. L., and Carpenter, C. B., 1977, Four patterns of human renal allograft rejection: A cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys, Transplant. Proc. 9:37.PubMedGoogle Scholar
  22. 22.
    Hall, B. M., Bishop, G. A., Farnsworth, A., Duggin, G. G., Horvath, J. S., Sheil, A. G. R., and Tiller, D. J., 1984, Identification of the cellular subpopulation infiltrating rejecting cadaver renal allografts, Transplantation 37:564.PubMedCrossRefGoogle Scholar
  23. 23.
    Reinherz, E. L., and Schlossman, S. F., 1980, The differentiation and function of human T lymphocytes, Cell 19:821.PubMedCrossRefGoogle Scholar
  24. 24.
    Reinherz, E. L., Kung, P. C., Goldstein, G., and Schlossman, S. F., 1979, A monoclonal antibody with selective reactivity with functionally mature thymocytes and all peripheral human T cells, J. Immunol. 123:1312.PubMedGoogle Scholar
  25. 25.
    Hansen, J. A., Martin, P. J., and Nowinski, R. C., 1980, Monoclonal antibodies identifying a novel T-cell antigen and Ia antigens of human lymphocytes, Immunogenetics 10:247.CrossRefGoogle Scholar
  26. 26.
    Carpenter, C. B., and Milford, E. L., 1985, Renal transplantation: Immunobiology, in: The Kidney (B. M. Brenner and F. C. Rector, eds.), 3rd ed., W. B. Saunders, Philadelphia, in press.Google Scholar
  27. 27.
    Reinherz, E. L., Meuer, S. C., and Schlossman, S. F., 1983, The delineation of antigen receptors on human T lymphocytes, Immunol. Today 4:5.CrossRefGoogle Scholar
  28. 28.
    Morimoto, C., Reinherz, E. L., Borel, Y., and Schlossman, S. F., 1983, Direct demonstration of the human suppresor inducer subset by anti-T cell antibodies, J. Immunol. 130:157.PubMedGoogle Scholar
  29. 29.
    Reinherz, E. L., Morimoto, C., Fitzgerald, K. A., Hussey, R. E., Daley, J. F., and Schlossman, S. F., 1982, Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations, J. Immunol. 128:463.PubMedGoogle Scholar
  30. 30.
    Damle, N. K., Mohagheghpour, N., Hansen, J. A., and Engleman, E. G., 1983, Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors, J. Immunol. 131:2296.PubMedGoogle Scholar
  31. 31.
    Evans, R. L., Faldetta, T. J., Humphreys, R. E., Pratt, D. M., Yunis, E. J., and Schlossman, S. F., 1978, Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express la-like antigens, J. Exp. Med. 148:1440.PubMedCrossRefGoogle Scholar
  32. 32.
    Reinherz, E. L., Kung, P. C., Pesando, J. M., Ritz, J., Goldstein, G., and Schlossman, S. F., 1979, Ia determinants on human T cell subsets defined by monoclonal antibody: Activation stimuli required for expression, J. Exp. Med. 150:1472.PubMedCrossRefGoogle Scholar
  33. 33.
    Uchiyama, T., Nelson, D. L., Fletcher, T. A., and Waldmann, T. A., 1981, A monoclonal antibody (antitac) reactive with activated and functionally mature human T cells II. Expression of tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper cells, J. Immunol. 126:1398.PubMedGoogle Scholar
  34. 34.
    Leonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A., and Greene, W. C., 1982, A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor, Nature 300:267.PubMedCrossRefGoogle Scholar
  35. 35.
    Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. P., Schlossman, S. F., and Reinherz, E. L., 1984, An alternative pathway of T-cell activation: A functional role for the 50 kD T11 sheep erythrocyte receptor protein, Cell 36:897.PubMedCrossRefGoogle Scholar
  36. 36.
    Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Acuto, O., Poole, C., Palley, L., Daley, J. F., Schlossman, S. F., and Reinherz, E. L., 1984, Ta1, a novel 105 kD human T cell activation antigen defined by a monoclonal antibody, J. Immunol. 133:1250.PubMedGoogle Scholar
  37. 37.
    Schultze, H. E., and Heremans, J. F., 1966, Nature and metabolism of extracellular proteins, in: Molecular Biology of Human Proteins, Volume 1, Elsevier, Amsterdam, pp. 473–477.Google Scholar
  38. 38.
    Reinherz, E. L., Meuer, S., Fitzgerald, K. A., Hussey, R. E., Levine, H., and Schlossman, S. F., 1982, Antigen recognition of human T lymphocytes is linked to surface expression of the T3 molecular complex, Cell 30:735.PubMedCrossRefGoogle Scholar
  39. 39.
    Estabrook, A., Berger, C. I., Mittler, R., LoGerfo, P., Hardy, M., and Edelson, R. L., 1983, Antigenic modulation of human T-lymphocytes by monoclonal antibodies, Transplant. Proc. 15:651.Google Scholar
  40. 40.
    Van Wauwe, F. P., DeMay, J. R., and Goossener, J. G., 1980, OKT3: A Monoclonal anti-human T lymphocyte antibody with potent mitogenic properties, J. Immunol. 124:2708.PubMedGoogle Scholar
  41. 41.
    Billing, R., Wells, J., Zettel, D., and Terasaki, P. I., 1982, Monoclonal and heteroantibody reacting with different antigens common to human blast cells and monocytes, Hybridoma 1:303.PubMedCrossRefGoogle Scholar
  42. 42.
    Cosimi, A. B., Burton, R. C., Kung, P. C., Colvin, R., Goldstein, G., Lifter, J., Rhodes, W., and Russell, P. S., 1981, Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell sub-classes, Transplant. Proc. 13:499.PubMedGoogle Scholar
  43. 43.
    Jonker, M., Malissen, B., van Vreeswijk, W., Mawas, C., Goldstein, G., Tax, W., and Balner, H., 1983, in vivo application of monoclonal antibodies specific for human T cell subsets permits the modification of immune responsiveness in rhesus monkeys, Transplant. Proc. 15:635.Google Scholar
  44. 44.
    Giorgi, J. V., Burton, R. C., Barrett, L. V., Delmonico, F. L., Goldstein, G., and Cosimi, A. B., 1983, Immunosuppressive effect and immunogenicity of OKT11A monoclonal antibody in monkey allograft recipients, Transplant. Proc. 15:639.Google Scholar
  45. 45.
    Bieber, C. P., Howard, F. D., Pennock, J., Wong, J., Shorthouse, R., and Stinson, E. B., 1981, Preparation, characterization and primate testing of monoclonal antithymocyte globulin, Transplantation 31:283.PubMedCrossRefGoogle Scholar
  46. 46.
    Cosimi, A. B., Colvin, R. B., Burton, R. C., Rubin, R. H., Goldstein, G., Kung, P., Hansen, W. P., Delmonico, F. L., and Russell, P. S., 1981, Use of monoclonal antibodies to T cell subsets for immunologic monitoring and treatment in recipients of renal allografts, N. Engl. J. Med. 305:308.PubMedCrossRefGoogle Scholar
  47. 47.
    Cosimi, A. B., Burton, R. C., Colvin, R. B., Goldstein, G., Delmonico, F. L., LaQuaglia, M. P., Tolkoff-Rubin, N., Rubin, R. H., Herrin, J. T., and Russell, P. S., 1981, Treatment of acute renal allograft rejection with OKT3 monoclonal antibody, Transplantation 32:535.PubMedCrossRefGoogle Scholar
  48. 48.
    Cosimi, A. B., 1983, The clinical usefulness of antilymphocyte antibodies, Transplant. Proc. 15:583.Google Scholar
  49. 49.
    Chatenoud, L., Baudrihaye, M. F., Chkoff, N., Kreis, H., and Bach, J. F., 1983, Immunologic followup of renal allograft recipients treated prophylactically by OKT3 alone, Transplant. Proc. 15:643.Google Scholar
  50. 50.
    Kirkman, R. L., Araujo, J. L., Busch, G. J., Carpenter, C. B., Milford, E. L., Reinherz, E. L., Schlossman, S. F., Strom, T. B., and Tilney, N. L., 1983, Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody, Transplantation 36:620.PubMedCrossRefGoogle Scholar
  51. 51.
    Carpenter, C. B., Milford, E. L., Reinherz, E. L., Schlossman, S. F., Tilney, N. L., Strom, T. B., Kirkman, R. L., Busch, G. J., and Araujo, J. L., 1983, Monoclonal anti-T12 antibody as therapy for renal allograft rejection, Trans. Assoc. Am. Physicians 96:84.PubMedGoogle Scholar
  52. 52.
    Hercend, T., Reinherz, E. L., Meuer, S., Schlossman, S. F., and Ritz, J., 1983, Phenotypic and functional heterogeneity of human cloned natural killer cell lines, Nature 301:158.PubMedCrossRefGoogle Scholar
  53. 53.
    Tilney, N. L., and Murray, J. E., 1967, The thoracic duct fistula as an adjunct to immunosuppression in human renal transplantation, Transplantation 5:1204.PubMedCrossRefGoogle Scholar
  54. 54.
    Billing, R., and Chatterjee, S., 1983, Prolongation of skin allograft survival in monkeys treated with anti-la and anti-blast/monocyte monoclonal antibodies, Transplant. Proc. 15:649.Google Scholar
  55. 55.
    Takahashi, H., Okazaki, H., Terasaki, P. I., Iwaki, Y., Kinukawa, T., Chia, D., Miura, K., Ishizaka, M., Taguchi, Y., and Billing, R., 1983, Reversal of transplant rejection by monoclonal antiblast antibody, Lancet 2:1155.PubMedCrossRefGoogle Scholar
  56. 56.
    Guttmann, R. D., Carpenter, C. B., Lindquist, R. R., and Merrill, J. P., 1967, Renal transplantation in the inbred rat. III. A study of heterologous antithymocyte sera, J. Exp. Med. 126:1099.PubMedCrossRefGoogle Scholar
  57. 57.
    Jaffers, G. J., Colvin, R. B., Cosimi, A. B., Giorgi, J. V., Goldstein, G., Fuller, T. C., Kurnick, J. T., Lillehei, C., and Russell, P. S., 1983, The human immune response to murine OKT3 monoclonal antibody, Transplant. Proc. 15:646.Google Scholar
  58. 58.
    Charpentier, B. M., Lang, P. P., Martin, B., and Freis, D., 1982, Specific recipient-donor unresponsiveness mediated by a suppressor cell system in human kidney allograft tolerance, Transplantation 33:470.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Charles B. Carpenter
    • 1
  1. 1.Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations